Fluocinonide in FAPG Base
| Autor: | T. M. Speight, G. S. Avery, R. N. Brogden |
|---|---|
| Rok vydání: | 1974 |
| Předmět: |
medicine.medical_specialty
Croton Oil Ultraviolet Rays Administration Topical Eczema Skin Diseases Drug Hypersensitivity Fluocinolone acetonide Psoriasis medicine Humans Vasoconstrictor Agents Pharmacology (medical) Radiation Injuries Inflammation business.industry medicine.disease Dermatology Fluocinonide Occlusive dressing Flumethasone pivalate Fluocinolone Acetonide Topical corticosteroid Propylene Glycols Fluocortolone Betamethasone Pharmaceutical Vehicles business Steroids Fluorinated medicine.drug |
| Zdroj: | Drugs. 7:337-343 |
| ISSN: | 0012-6667 |
| DOI: | 10.2165/00003495-197407050-00004 |
| Popis: | Fluocinonide (fluocinolone acetonide acetate) 0.05 % in FAPG base2 is a new fluorinated topical corticosteroid incorporated into a specially formulated non-aqueous synthetic base for use in psoriasis, eczema and other inflammatory dermatoses. In double-blind paired comparisons with other fluorinated topical corticosteroid creams, fluocinonide in FAPG base has generally been at least as effective as normally used concentrations of fluocortolone, flumethasone pivalate and betamethasone 17-valerate in eczema and more effective than these topical corticosteroids in psoriasis except when used with occlusive dressings, when no difference could be found. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink